Table 1.
Demographic, laboratory, and epidemiological parameters of individuals with human immunodeficiency virus infection
| HIV/AIDS patients | Toxoplasma DNA positive | Toxoplasma DNA negative | Total | P value | |
|---|---|---|---|---|---|
| No. of patients | |||||
| Male | 4 (100%) | 62 (59.6%) | 66 (61.1%) | 0.134 | Fisher’s exact test |
| Female | 0 (0.0%) | 42 (40.4%) | 42 (38.9%) | ||
| Age (year) ± SD | 49.5 ± 3.1 (46–53) | 39.4 ± 10.5 (5–60) | 39.7 ± 10.5 (5–60) | 0.059 | T test |
| Laboratory parameters | |||||
| Viral load IU/mL (median) | 50610.0 (39564–58325) | 4593.0 (75–1011793) | 6118.5 (75–1011793) | 0.163 | Mann–Whitney U |
| CD4 count | 51.5 ± 34.5 (17–98) | 415.1 ± 211.3 (89–900) | 401.4 ± 218.7 (17–900) | 0.001a | T test |
| ALT1 (IU/L) | 45.7 ± 8.4 (38–54) | 48.5 ± 18.6 (21–91) | 48.4 ± 18.3 (21–91) | 0.948 | Mann–Whitney U |
| AST2 (IU/L) | 41 ± 8.2 (33–49) | 43.1 ± 17.3 (19–83) | 43.0 ± 17.0 (19–83) | 0.896 | Mann–Whitney U |
| Toxoplasma IgG antibody | 4 (100%) | 91 (87.5%) | 95 (88%) | 0.594 | Fisher’s exact test |
| Toxoplasma IgM antibody | 1 (25%) | 0 (0%) | 1 (0.92%) | 0.963 | |
| Epidemiological parameters | |||||
| IVDU | 2 (50.0%) | 50 (48.1%) | 52 (48.1%) | 0.662 | Fisher’s exact test |
| IVDU partner | 0 (0%) | 32 (30.8%) | 32 (29.6%) | 0.239 | Fisher’s exact test |
| History of imprison | 1 (25.0%) | 46 (44.2%) | 47 (43.5%) | 0.413 | Fisher’s exact test |
| Tattooing | 0 (0%) | 18 (17.3%) | 18 (16.7%) | 0.477 | Fisher’s exact test |
| Needle stick | 0 (0%) | 16 (15.4%) | 16 (14.8%) | 0.521 | Fisher’s exact test |
| Unprotected Sex | 0 (0%) | 40 (38.5%) | 40 (37.0%) | 0.152 | Fisher’s exact test |
| Mother to child | 0 (0%) | 2 (1.9%) | 2 (1.9%) | 0.927 | Fisher’s exact test |
| Blood transfusion | 0 (0%) | 2 (1.9%) | 2 (1.9%) | 0.927 | Fisher’s exact test |
1Alanine aminotransferase (ALT); 2 Aspartate aminotransferase (AST); a Statistically Significant